Newsletter
Search
'Strict Supervision Needed': Pharmarack's Sheetal Sapale On India's Anti-Obesity Drug Boom
Sapale also spoke about why these particular drugs are so popular and the possible long-term challenges that can arise from taking them.
Markets Slide Down In Search of Fresh Traction
The stock markets were down after a good run in the previous week
The Markets Go Flat in Search Of Signals
The Indian markets are flat and traded narrowly on Thursday
Markets Recover, Await Economic Data
US equity futures were steady to positive again overnight as most investors were holding back for fresh economic data and Federal Reserve signals on the timing and prospects of interest rate cuts in the US
Indian Markets Rise For 5th Consecutive Session
The indices ended higher for the fifth consecutive session on Monday, usually a sign that the markets might pause to take in some air. December quarter earnings are now over and the focus is back on macroeconomic news.
Quick Fix For Weight Loss Fuels Growth Of Anti-Obesity Drug Market
In India, the anti-obesity drug semaglutide is sold in pills under the brand name Rybelsus.
For Foreign Investors, India Is A Debt Story Right Now
In the last 10 days, FIIs have already invested over Rs 15,000 crore over close to Rs 20,000 crore in January, so Rs 35,000 crore in all, according to a report in PTI quoted by NDTV Profit
The IMF Has Raised FY24 India Growth Projection To 6.3%
The IMF's latest World Economic Outlook (WEO) kept its global growth forecast unchanged at 3 per cent for 2023 while paring down the 2024 projection by 10 basis points to 2.9 per cent
